| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Kala Pharmaceuticals Inc (NASDAQ: KALA)
KALA Technical Analysis
5
| As on 1st Dec 2025 KALA SHARE Price closed @ 1.33 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 6.43 & Strong Sell for SHORT-TERM with Stoploss of 7.49 we also expect STOCK to react on Following IMPORTANT LEVELS. |
KALASHARE Price
| Open | 1.30 | Change | Price | % |
| High | 1.91 | 1 Day | 0.36 | 37.11 |
| Low | 1.17 | 1 Week | 0.70 | 111.11 |
| Close | 1.33 | 1 Month | 0.02 | 1.53 |
| Volume | 168893176 | 1 Year | -5.53 | -80.61 |
| 52 Week High 19.63 | 52 Week Low 0.62 | ||||
NASDAQ USA Most Active Stocks
| LPTX | 2.05 | 365.91% |
| AMRS | 0.14 | 100.00% |
| WBA | 11.98 | 0.50% |
| BYND | 1.34 | 36.73% |
| NVDA | 179.92 | 1.65% |
| KALA | 1.33 | 37.11% |
| LMDX | 0.02 | 0.00% |
| AKTS | 0.04 | 0.00% |
| BITF | 3.28 | -5.75% |
| OPEN | 7.14 | -7.27% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| KALA Daily Charts |
KALA Intraday Charts |
Whats New @ Bazaartrend |
KALA Free Analysis |
|
|
KALA Important Levels Intraday
| RESISTANCE | 2.76 |
| RESISTANCE | 2.30 |
| RESISTANCE | 2.02 |
| RESISTANCE | 1.73 |
| SUPPORT | 0.93 |
| SUPPORT | 0.64 |
| SUPPORT | 0.36 |
| SUPPORT | -0.10 |
KALA Forecast December 2025
| 4th UP Forecast | 7.34 |
| 3rd UP Forecast | 5.41 |
| 2nd UP Forecast | 4.22 |
| 1st UP Forecast | 3.03 |
| 1st DOWN Forecast | -0.37 |
| 2nd DOWN Forecast | -1.56 |
| 3rd DOWN Forecast | -2.75 |
| 4th DOWN Forecast | -4.68 |
KALA Weekly Forecast
| 4th UP Forecast | 2.64 |
| 3rd UP Forecast | 2.22 |
| 2nd UP Forecast | 1.96 |
| 1st UP Forecast | 1.70 |
| 1st DOWN Forecast | 0.96 |
| 2nd DOWN Forecast | 0.70 |
| 3rd DOWN Forecast | 0.44 |
| 4th DOWN Forecast | 0.02 |
KALA Forecast2025
| 4th UP Forecast | 39.85 |
| 3rd UP Forecast | 27.5 |
| 2nd UP Forecast | 19.86 |
| 1st UP Forecast | 12.22 |
| 1st DOWN Forecast | -9.56 |
| 2nd DOWN Forecast | -17.2 |
| 3rd DOWN Forecast | -24.84 |
| 4th DOWN Forecast | -37.19 |
Kala Pharmaceuticals Inc ( NASDAQ USA Symbol : KALA )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
KALA Business Profile
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary nanoparticle-based Mucus Penetrating Particles (MPP) technology for the treatment of eye diseases. The company's product candidates include EYSUVIS for the short-term treatment of the signs and symptoms of dry eye disease; and INVELTYS, a topical twice-a-day ocular steroid for the treatment of post-operative inflammation and pain following ocular surgery. Its preclinical development programs comprise KPI-285/KPI-286, a receptor tyrosine kinase inhibitor program for the treatment of various retinal diseases; SEGRM program, a novel class of compounds designed to regulate gene expression through the transrepression pathway while avoiding the transactivation pathway; and surface targeted steroid program (KPI-333), a new chemical entity as a topical steroid that targets the ocular surface. The company was formerly known as Hanes Newco, Inc. and changed its name to Kala Pharmaceuticals, Inc. in December 2009. Kala Pharmaceuticals, Inc. was incorporated in 2009 and is headquartered in Watertown, Massachusetts. Address: 490 Arsenal Way, Watertown, MA, United States, 02472
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service